Psychosocial Impacts of Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer: A Narrative Review

预防性全胃切除术对遗传性弥漫型胃癌患者的心理社会影响:一项叙述性综述

阅读:2

Abstract

BACKGROUND: Pathogenic or likely pathogenic (P/LP) CDH1 germline genetic variants are causally linked to early onset diffuse gastric cancer and prophylactic total gastrectomy (PTG) is a recommended intervention for (P/LP) CDH1 variant carriers. However, PTG introduces fundamental challenges to a patient's quality of life (QOL) and psychological well-being. There is a growing need for evidence-based recommendations to address the psychosocial needs of PTG patients. The present review summarizes published literature on psychosocial sequelae and quality of life reported post-PTG in germline (P/LP) CDH1 variant carriers. METHODS: Articles were extracted from the PubMed database using the following search terms: "total gastrectomy", "CDH1", "CTNNA1", "guidelines", "psychological", "psychiatric", "mental health", "quality of life", and "longitudinal". Articles that address psychological and QOL implications and outcomes for PTG or total gastrectomy (TG) patients were included. Articles that mentioned "psychosocial factors" generally, without specific details, were excluded. RESULTS: 37 articles met inclusion criteria. Seven of the most frequently mentioned psychosocial domains in the published literature include quality of life (n = 22), social relationships (n = 12), depression and anxiety (n = 8), decision-making (n = 7), employment and finances (n = 4), body image (n = 5), and substance abuse (n = 3). CONCLUSIONS: Considering the known psychological impact of a genetic cancer predisposition diagnosis and the significant postoperative lifestyle adjustment, this review identifies a need for standardized integration of mental health care along the PTG surgical continuum. The combination of the diagnosis of a hereditary cancer syndrome and the life-altering nature of prophylactic total gastrectomy (PTG) presents a psychosocial vulnerability for CDH1 (P/LP) variant carriers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。